849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Trastuzumab Deruxtecan Breast Cancer	SWOG Cancer Research Network	P4	BB (66)
Trastuzumab Emtansine Breast Cancer	SWOG Cancer Research Network	P3	BB (66)
Alisertib Breast Cancer	Puma Biotechnology, Inc.	P2	BB (65)
Dexasone Breast Cancer	Beijing Biostar Pharmaceuticals Co., Ltd.	P4	BB (65)
Hrs-1358 Breast Cancer	Henan Cancer Hospital	P2	BB (65)
Ketorolac Breast Cancer	Cairo University	P4	BB (65)
Lenvatinib Breast Cancer	Jiuda Zhao	P3	BB (65)
Ondansetron Breast Cancer	Chinese University of Hong Kong	P4	BB (65)
Romidepsin Breast Cancer	Mayo Clinic	P2	BB (65)
Toremifene Breast Cancer	Tianjin Medical University Cancer Institute and Hospital	P4	BB (65)
VENLOR Breast Cancer	University of Illinois at Chicago	P4	BB (65)
bnt323 Breast Cancer	BioNTech SE	P3	BB (64)
Daunomycin Breast Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P4	BB (64)
Denosumab Breast Cancer	Alliance for Clinical Trials in Oncology	P4	BB (64)
Fentanyl Breast Cancer	Aga Khan University	P4	BB (64)
Fes F-18 Breast Cancer	University of Washington	P3	BB (64)
Lapatinib Breast Cancer	University of New Mexico	P3	BB (64)
Metformin Breast Cancer	City of Hope Medical Center	P4	BB (64)
Nilotinib Breast Cancer	National Cancer Institute (NCI)	P2	BB (64)
Ranitidine Breast Cancer	Ohio State University Comprehensive Cancer Center	P2/3	BB (64)
Rivoceranib Breast Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P4	BB (64)
Ropivacaine Breast Cancer	Aldy Aldy	P4	BB (64)
Tucidinostat Breast Cancer	Beijing 302 Hospital	P4	BB (64)
Atirmociclib Breast Cancer	AstraZeneca	P3	B (63)
Bortezomib Breast Cancer	Sun Yat-sen University	P2	B (63)
Encequidar Breast Cancer	Health Hope Pharma	P3	B (63)
Giredestrant Breast Cancer	Genentech, Inc.	P3	B (63)
Hrs-8080 Breast Cancer	Shandong Suncadia Medicine Co., Ltd.	P3	B (63)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide Breast Cancer	Sichuan Baili Pharmaceutical Co., Ltd.	P3	B (63)
Isosulfan Blue Breast Cancer	University of Wisconsin, Madison	P3	B (63)
Midazolam Breast Cancer	Jun Zhang	P4	B (63)
Pregabalin Breast Cancer	Jules Bordet Institute	P4	B (63)
Pyrotinib Breast Cancer	Fudan University	P4	B (63)
Rosuvastatin Breast Cancer	Shiraz University of Medical Sciences	P4	B (63)
Syhx2011 Breast Cancer	CSPC Ouyi Pharmaceutical Co., Ltd.	P3	B (63)
Toripalimab Breast Cancer	Zhejiang Cancer Hospital	P4	B (63)
Vepdegestrant Breast Cancer	Pfizer	P3	B (63)
Vismodegib Breast Cancer	OHSU Knight Cancer Institute	P2	B (63)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Breast Cancer	Aga Khan University	P4	B (62)
Copper Cu 64-Dota-Trastuzumab Breast Cancer	City of Hope Medical Center	P4	B (62)
Dapagliflozin Breast Cancer	Tanta University	P4	B (62)
Diphenhydramine Breast Cancer	Beijing Biostar Pharmaceuticals Co., Ltd.	P3	B (62)
Fludeoxyglucose Breast Cancer	Peking University Cancer Hospital & Institute	P2	B (62)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Breast Cancer	National Cancer Institute (NCI)	P2	B (62)
Perflutren Lipid Microsphere Intravenous Suspension Breast Cancer	UNC Lineberger Comprehensive Cancer Center	P2/3	B (62)
Propofol Breast Cancer	University of Rijeka	P4	B (62)
Abemaciclib Breast Cancer	Fudan University	P4	B (61)
Atezolizumab Breast Cancer	The Netherlands Cancer Institute	P3	B (61)
Atorvastatin Breast Cancer	UNC Lineberger Comprehensive Cancer Center	P4	B (61)
Capivasertib Breast Cancer	Maryam Lustberg	P3	B (61)

Showing 51 to 100 of 849 assets

PreviousPage 2 of 17Next